Repurposing of FDA-approved drugs as novel therapeutics for COVID-19
Currently, there is no vaccine or effective therapeutics for COVID-19, which is caused by 2019-nCoV (now officially referred to as SARS-CoV-2). Tens of thousands of people get infected by SARS-CoV-2 and substantial percentage of them showed severe symptoms. Dr Wu’s team proposed to rapidly screen database of FDA-approved drugs by computationally approaches and further evaluate the top-ranking candidates by an array of experimental assays. This project could rapidly lead to drug candidates for COVID-19.